The Effect of Acupuncture on Pregnancy Rates in Women Undergoing in Vitro Fertilization With Preimplantation Genetic Screening
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03981120|
Recruitment Status : Not yet recruiting
First Posted : June 10, 2019
Last Update Posted : June 11, 2019
University of British Columbia
Information provided by (Responsible Party):
Gary Nakhuda, University of British Columbia
While IVF offers an effective treatment for infertility, a significant proportion of IVF cycles still result in failed implantation and early miscarriage. As such, new therapies that improve pregnancy outcomes are highly desirable. Both traditional and laser acupuncture during the IVF cycle has become a popular option for women looking to improve their pregnancy rates. However, studies looking to understand the effects of acupuncture on IVF have demonstrated contradicting results. While some studies show an improvement in pregnancy rates in women undergoing IVF with traditional acupuncture treatment, other studies show no difference. Moreover, there are few studies exploring the role of laser acupuncture in IVF cycles and the studies done thus far have shown no change in pregnancy rates. However, there have been no studies to-date that have looked at women who are receiving IVF for embryos with normal genetics. This is important because embryos with abnormal genetics are a major reason for failed implantation and miscarriage, which can make the effects of acupuncture on pregnancy rates difficult to evaluate. This study is a pilot study looking to better understand the role of laser acupuncture as a supplemental treatment in women undergoing euploid (normal genetics) embryo transfer. This is the first study to include only genetically normal embryos, which may help to better understand the effects of laser acupuncture on IVF outcomes.
|Condition or disease||Intervention/treatment||Phase|
|Infertility Aneuploidy||Procedure: Laser Acupuncture||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Care Provider, Investigator, Outcomes Assessor)|
|Masking Description:||Participants will be assigned a computer generated code to be used on data collection forms.|
|Official Title:||The Effect of Acupuncture on in Vitro Fertilization Outcomes in Women Undergoing Euploid Embryo Transfer - A Pilot Study|
|Estimated Study Start Date :||July 15, 2019|
|Estimated Primary Completion Date :||November 1, 2019|
|Estimated Study Completion Date :||January 1, 2020|
No Intervention: Standard Care Group
Patients in the control arm will lie down in a relaxing environment for the same duration allotted to acupuncture treatment. The treatment and control group will be compared to the baseline pregnancy rate of women meeting the same inclusion and exclusion criteria from the clinic through a chart review over the two years prior to initiation of the study.
Experimental: Laser Acupuncture Group
The acupuncture arm will follow the Delphi consensus, which includes (1) a treatment session on day 6-8 of controlled ovarian hyperstimulation and will include core points ST29, CV4, CV6. SP6, SP10, +5 additional points to be individualized to each patient, (2) a second treatment before ET using points SP8, SP10, LR3, ST29, CV4 and one selected from HT7/PC6/YingTang depending on the individual patient, (3) a third treatment within 48 hours post-ET using points GV20, KD3, ST36. SP6, PC6 and auricular acupuncture points Shenmen and Zigong (only to be used on the day of ET).
Procedure: Laser Acupuncture
Acupuncture will be performed by a certified acupuncturist on-site with experience in reproductive health and the initial visit will include an assessment and traditional Chinese medicine (TCM) diagnosis, in keeping with the semi-standardized Delphi consensus protocol.
Primary Outcome Measures :
- Overall Pregnancy Rate [ Time Frame: From date of embryo transfer until the date of first documented pregnancy, whichever comes first, up to 12 months ]Pregnancy beyond 10 weeks' gestation
Secondary Outcome Measures :
- Biochemical Pregnancy Rate [ Time Frame: From date of embryo transfer until the date of first documented biochemical pregnancy, whichever comes first, up to 12 months ]positive human chorionic gonadotropin (hCG) serum or urine test > or = 11 days after embryo transfer
- Cumulative Pregnancy Rate [ Time Frame: From date of embryo transfer until the date of first documented intrauterine pregnancy, whichever comes first, up to 12 months ]Presence of at least one intrauterine gestational sac or fetal heartbeat confirmed by ultrasound 4-6 weeks after embryo transfer
- Live Birth Rate [ Time Frame: From date of embryo transfer until the date of birth, whichever comes first, up to 12 months ]Baby born alive after 24 weeks gestation
Other Outcome Measures:
- Rate of miscarriage [ Time Frame: From date of embryo transfer until diagnosis, up to 12 months. ]Loss of pregnancy
- Rate of adverse events [ Time Frame: Any time during study period up to 12 months ]Any unfavourable outcome from medication or procedures.
No Contacts or Locations Provided